US Dermatologt Partners

JUNE 1, 2024

In the ever-evolving landscape of psoriasis treatment, oral therapies continue to play a crucial role. 2 Newer Generation Oral Therapies “We live in an exciting time because we’ve got new topical therapies, multiple oral therapies, and obviously, an array of biologic agents and patient preferences change,” Lockshin said.

Therapy 41

Therapy Injections Safety Management 41

New Age Spa Institute

NOVEMBER 20, 2024

Certifications are typically focused on specific skills, such as makeup artistry, clinical aesthetics, or advanced techniques in skincare. Licenses like those for esthetics, cosmetology , and massage therapy give professionals the legal right to practice their craft and offer services to the public. Don’t forget!

Esthetics 52

Esthetics Therapy Continuing Education Continuous Education 52

The Dermatology Digest

FEBRUARY 11, 2024

A meta-analysis of 45 randomized clinical trials comprised of 12,996 patients disclosed neither an increased risk of major cardiovascular events (MACE) such as heart attack and stroke) nor of venous thromboembolic events (VTE). This particular study did not address other safety concerns, such as all-cause mortality, infections, or cancer.

Dermatology 74

Dermatology Safety Clinic Therapy 74

The Dermatology Digest

JULY 24, 2024

This BLA/MAA for BAT2206 is based on the totality of evidence comprising a comprehensive analytical, non-clinical and clinical data package. A Biologics License Application seeking approval for BAT2206 is also currently under review by the China National Medicinal Product Administration (NMPA).

Dermatology 78

Dermatology Sales Marketing Safety 78

The Dermatology Digest

FEBRUARY 14, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. In the ARCADIA program, nemolizumab clinically improved skin lesions and rapidly improved itch and sleep disturbance.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

JUNE 5, 2024

The randomized, double-blind, vehicle-controlled trial will evaluate the safety and efficacy of once-daily VYN201 topical gel in three dose cohorts (1%, 2% and 3% concentrations) compared to vehicle for 24 weeks. We believe that VYN201 has the potential to become a valuable and differentiated therapy for patients with vitiligo.

Safety 73

Safety Office Facials Therapy 73

The Dermatology Digest

FEBRUARY 8, 2024

This will be a game-changer if it pans out and may get us closer to disease cures via optimization of existing biological therapies,” he says. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.” Hands Up for New CHE therapies Chronic hand eczema (CHE) will also get some love in 2024.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

DECEMBER 13, 2024

Food and Drug Administration (FDA) has approved nemolizumab (Nemluvio, Galderma) for the treatment of patients aged 12 and older with moderate to severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies.

Dermatitis 69

Dermatitis Safety Eczema Dermatology 69

Dermatology Times

DECEMBER 5, 2024

James Song, MD, discusses how clinical trial data demonstrates the risk-benefit profile of vitiligo therapies, with particular focus on balancing potential adverse effects of Janus kinase inhibitors against their proven efficacy in achieving repigmentation.

Safety 36

Safety Therapy Clinic 36

Alison Bladh

JANUARY 16, 2025

Clinical studies indicate that saw palmetto can be an effective option for managing urinary symptoms during perimenopause and menopause, improving quality of life for many women. Interactions Saw palmetto may interact with hormonal therapies, including birth control or hormone replacement therapy (HRT).

Extractions 98

Extractions Management Consultation Consultations 98

The Dermatology Digest

APRIL 4, 2024

The sBLA in moderate-to-severe HS is supported by data from the Phase 3 BE HEARD I and BE HEARD II studies where Bimzelx demonstrated clinically meaningful improvements in Hidradenitis Suppurativa Clinical Response-50 (HiSCR50) vs. placebo at Week 16, the primary endpoint. Bimzelx was approved in the U.S. In the U.S.,

Safety 57

Safety Injections Clinic Therapy 57

Aesthetics Advisor

AUGUST 18, 2023

Key Points: A few studies show that NAD+ IV therapy can alleviate alcohol and drug addiction, as well as Parkinson’s disease, but no studies have examined its effects on aging. Oral administration of NAD+ boosting therapy is safer, more cost effective, and more consistently dosed than intravenous administartion.

Therapy 36

Therapy Injections Safety Clinic 36

The Dermatology Digest

MAY 22, 2024

The first patient has been dosed in Zai Lab’s global Phase 2 clinical trial of ZL-1102, a topical anti-IL-17 investigational therapy for the treatment of mild to moderate chronic plaque psoriasis. In this 5-arm trial, approximately 250 patients will receive topical therapy for 16 weeks.

Clinic 36

Clinic Therapy Safety Treatments 36

The Dermatology Digest

SEPTEMBER 20, 2024

s Investigational Device Exemption (IDE) application to initiate a multi-center study for the treatment of recurrent cutaneous Squamous Cell Carcinoma (cSCC) in immunocompromised patients using Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT). Food and Drug Administration (FDA) has approved Alpha Tau Medical Ltd.’s

Office 74

Office Clinic Safety Medical 74

The Dermatology Digest

MARCH 12, 2024

in patients with HS met its primary endpoint, reinforcing the efficacy and safety profile of ruxolitinib cream 1.5%, demonstrating potential as a novel treatment option for people living with HS,” study author Martina J. The Phase 2 study evaluating ruxolitinib cream, 1.5% achieved a 75% reduction (AN75), 20.8%

Therapy 69

Therapy Safety Dermatology Treatments 69

The Dermatology Digest

FEBRUARY 16, 2024

One of the biggest challenges in CAR T-cell therapies is the scarcity of suitable tumor targets,” says study author Cristina Puig-Saus, PhD, assistant professor of medicine at the David Geffen School of Medicine at UCLA, in a news release.

Therapy 36

Therapy Clinic Safety Treatments 36

Aesthetics Advisor

JULY 4, 2024

In recent years, the allure of IV drip therapy has surged, captivating both health enthusiasts and celebrities alike. In an exploration of the scientific realms of IV drip therapy, we talked to Dr. Anant Vinjamoori, MD, Chief Medical Officer of Modern Age and Harvard-trained longevity expert. What is IV drip therapy?

Therapy 36

Therapy Vitamin C Injections Medical 36

Alison Bladh

JANUARY 1, 2025

Medical and Cosmetic Solutions Platelet-Rich Plasma (PRP) Therapy : This treatment involves injecting your plasma into the brow area to stimulate hair growth. Dermatologic Therapy. Platelet-Rich Plasma Therapy for Hair Growth: A Systematic Review. Dermatology Clinics. Clinical and Aesthetic Dermatology.

Treatments 52

Treatments Skincare Routine Hydration Therapy 52

New Age Spa Institute

DECEMBER 18, 2024

Also known as NASI , this private beauty school in Des Plaines, IL offers training programs for professional licensing in esthetics, massage therapy, makeup, and more. Certifications are targeted programs designed to enhance your knowledge and skills in specific areas of esthetics, cosmetology, or massage therapy. Want more info?

Medical 52

Medical Esthetics Legal Continuous Education 52

New Age Spa Institute

SEPTEMBER 19, 2024

Let’s take a closer look at the safety concerns surrounding UV lashes: Light Strength Comparison: The LED light used in UV lash extensions is typically 5 watts, much less powerful than a nail lamp (50+ watts) or a tanning bed (1,500-2,000 watts). But I’m cautious about long-term safety, especially with UV exposure near the eyes.”

Lash Extensions 52

Lash Extensions Safety Irritation Makeup 52

The Dermatology Digest

DECEMBER 4, 2024

Restem’s ULSC therapy has shown promising results in early clinical trials, demonstrating safety, tolerability and initial clinically significant improvements, as well as the potential to significantly reduce the need for steroid use in patients.

Treatments 36

Treatments Office Therapy Clinic 36

The Dermatology Digest

FEBRUARY 16, 2024

for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy. The safety profile of dupilumab in CSU was generally consistent with the known safety of Dupixent in its approved dermatological indications. and Novartis Pharmaceuticals).

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

Aesthetics Advisor

AUGUST 15, 2023

Curcumin may help increase healthy p53 levels, and it has been shown to be a potentially effective cancer therapy supplement. Since fenbendazole is a veterinary medicine, and is not licensed for human use and there is no specific human safety data available. Click here to buy Theracurmin HP by Integrative Therapeutics (Amazon) 3.

Therapy 69

Therapy Medical Safety Diet 69

Aesthetics Advisor

AUGUST 19, 2023

Nevertheless, PRP and exosome-related therapies are not yet established as standard treatments, given their relatively recent emergence. Because the human body is specially equipped to heal itself, and regenerative therapies tap into this powerful ability. Regenerative medicine is also becoming a buzzword in the medical community.

Therapy 36

Therapy Injections Medical Treatments 36

The Dermatology Digest

AUGUST 30, 2024

The safety profile of pembrolizumab in this trial was consistent with the drug’s established safety profile. The primary endpoint is RFS, and key secondary endpoints include OS and safety. The DMC stated that the study be stopped as the risk/benefit profile did not support continuing it.

Surgery 36

Surgery Safety Therapy Innovations 36

Lipgloss and Aftershave

NOVEMBER 1, 2024

Whether caused by sun exposure, hormonal fluctuations, post-inflammatory responses, or genetic factors, pigmentation can present unique challenges in clinical practice. In 2016, Krystal completed her clinical doctorate in nursing practice. Tranexamic Acid in Dermatology: Current Perspectives and Clinical Outcomes. Farris, P.

Chemical Peels 52

Chemical Peels Hyperpigmentation Vitamin C Microneedling 52

The Dermatology Digest

MARCH 5, 2024

APG777 is the first clinical-stage product candidate from the company’s strategic collaboration with Paragon Therapeutics, Inc. Based on these data, the company plans to initiate a randomized, placebo-controlled, Phase 2 clinical trial in patients with moderate-to-severe AD in the first half of 2024 ahead of schedule.

Injections 36

Injections Safety Sustainability Clinic 36

The Dermatology Digest

APRIL 17, 2024

Patient enrollment is now complete in Celldex’s Phase 2 clinical study of barzolvolimab for the treatment of the two most common forms of chronic inducible urticaria (CIndU)—cold urticaria (ColdU) and symptomatic dermographism (SD).

Safety 36

Safety Injections Office Therapy 36

The Dermatology Digest

NOVEMBER 30, 2024

Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Incyte is investigating the efficacy and safety of ruxolitinib cream in cutaneous lichen planus.

Pharmaceutical 36

Pharmaceutical Safety Marketing Therapy 36

The Dermatology Digest

MAY 23, 2024

Bimekizumab-bkzx (Bimzelx, UCB) consistently showed sustained improvements in clinical and patient-reported outcomes in patients with moderate to severe hidradenitis suppurativa (HS), according to results from the Phase 3 BE HEARD I and BE HEARD II trials. Bimekizumab-bkzx is an interleukin (IL)-17A and IL-17F inhibitor.

Sustainability 36

Sustainability Safety Clinic Medical 36

Eminence Organics

FEBRUARY 27, 2024

It's time to explore the latest in wellness: salt halotherapy (or salt therapy). Along with these newer therapies, we'll also discuss scientifically proven salt treatments, like salt scrubs, to give you a comprehensive view. Improved Circulation: There are suggestions that salt therapy can enhance blood circulation.

Treatments 59

Treatments Therapy Training Exfoliation 59

New Age Spa Institute

DECEMBER 19, 2023

To Qualify for an Massage Therapy License, what’s needed? Massage Therapy License candidates need a high school diploma or GED and must complete fingerprints and a criminal background check. How To Start a Massage Therapist Career What happens after completing your massage therapy program and obtaining your license?

Private Practice 40

Private Practice Ethics Therapy Education 40

The Dermatology Digest

JANUARY 13, 2025

Rezpegaldesleukin is a first-in-class interleukin-2 receptor (IL-2R) agonist that proliferates and activates regulatory T cells (Tregs) with promising dose-dependent clinical activity in multiple skin disease settings. Robin, President and CEO of Nektar Therapeutics, in a news release.

Dermatitis 36

Dermatitis Clinic Eczema Therapy 36

AAAMS

MAY 9, 2024

These programs usually combine theoretical knowledge with hands-on clinical experience to ensure that nurses are skilled in delivering safe and effective aesthetic treatments. Nurses were first taught the importance of maintaining a clean and sterile environment, with safety being the top priority.

Training 52

Training Technology Ethics Injections 52

The Dermatology Digest

JUNE 14, 2024

ICP-332 achieved multiple efficacy endpoints in the China Phase II study of patients with moderate-to-severe AD and demonstrated an “outstanding” and safety profile. ICP-332 showed better efficacy profile across different classes and mechanisms of action of therapies for the treatment of AD patients although this was not a head-to-head study.

Dermatitis 36

Dermatitis Marketing Safety Innovations 36

The Dermatology Digest

MAY 8, 2024

The safety profile of subcutaneous nivolumab was consistent with the IV formulation. The pharmacokinetics, efficacy, and safety results from CheckMate -67T were presented at the American Society of Clinical Oncology (ASCO) 2024 Genitourinary Cancers Symposium.

Safety 36

Safety Therapy Injections Dermatology 36

New Age Spa Institute

OCTOBER 3, 2024

At New Age Spa Institute, we introduce safer, prostaglandin-free options in our curriculum and continuing education classes like Master Clinical Aesthetics. For those ready to dive deeper, our Eyelash Extension Certification course provides a comprehensive look into lash extension application, maintenance, and safety. </p>

Continuous Education 52

Continuous Education Continuing Education Lash Extensions Makeup 52